CIK 0001628171 · Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472029180
- Phone
- 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,328,124
- in 21 filings, $85.3M under 10b5-1 plans
Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-26 | Mancini Anthony See Remarks | Option exercise 10b5-1 | +3,121 | $33.62 | $105K | 57,521 |
| 2026-05-26 | Mancini Anthony See Remarks | Sale 10b5-1 | −700 | $153.30 | $107K | 56,821 |
| 2026-05-26 | Mancini Anthony See Remarks | Sale 10b5-1 | −2,000 | $154.06 | $308K | 54,821 |
| 2026-05-26 | Mancini Anthony See Remarks | Sale 10b5-1 | −421 | $154.82 | $65K | 54,400 |
| 2026-05-26 | Mancini Anthony See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,121 | 106,109 | ||
| 2026-04-27 | Mancini Anthony See Remarks | Option exercise 10b5-1 | +3,120 | $33.62 | $105K | 57,520 |
| 2026-04-27 | Mancini Anthony See Remarks | Sale 10b5-1 | −1,671 | $131.66 | $220K | 55,849 |
| 2026-04-27 | Mancini Anthony See Remarks | Sale 10b5-1 | −1,049 | $132.88 | $139K | 54,800 |
| 2026-04-27 | Mancini Anthony See Remarks | Sale 10b5-1 | −400 | $134.34 | $54K | 54,400 |
| 2026-04-27 | Mancini Anthony See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,120 | 109,230 | ||
| 2026-04-15 | GOLDSMITH MARK A See Remarks | Option exercise 10b5-1 | +23,244 | $4.09 | $95K | 299,942 |
| 2026-04-15 | GOLDSMITH MARK A See Remarks | Option exercise 10b5-1 | +96,756 | $4.73 | $458K | 396,698 |
| 2026-04-15 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −120,000 | $150.09 | $18.0M | 276,698 |
| 2026-04-15 | GOLDSMITH MARK A See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,244 | 24,464 | ||
| 2026-04-15 | GOLDSMITH MARK A See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −96,756 | 424,085 | ||
| 2026-03-25 | Mancini Anthony See Remarks | Option exercise 10b5-1 | +37,450 | $33.62 | $1.3M | 91,850 |
| 2026-03-25 | Mancini Anthony See Remarks | Sale 10b5-1 | −1,800 | $93.22 | $168K | 90,050 |
| 2026-03-25 | Mancini Anthony See Remarks | Sale 10b5-1 | −3,128 | $94.16 | $295K | 86,922 |
| 2026-03-25 | Mancini Anthony See Remarks | Sale 10b5-1 | −21,086 | $95.49 | $2.0M | 65,836 |
| 2026-03-25 | Mancini Anthony See Remarks | Sale 10b5-1 | −11,036 | $96.43 | $1.1M | 54,800 |
Page 10 of 18 · 352 trades